002064 华峰化学
2025/09 - 九个月
人民幣(K¥)
与去年同期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
营业总收入18,109,485-11.11%26,931,40726,298,46125,884,10628,367,202
减:营业总成本16,685,705-8.87%24,617,26123,744,13422,830,70619,227,956
    其中:营业成本15,557,412-9.52%23,205,47022,262,19221,242,01917,388,876
               财务费用(80,354)-34.23%(136,147)(145,582)(203,037)30,992
               资产减值损失(16,135)524.96%(180,558)(51,693)(89,624)(32,754)
公允价值变动收益10,79898.26%2,336(2,778)(2,342)(1,334)
投资收益95,7706.84%127,44593,504105,79369,515
    其中:对联营企业和合营企业的投资收益56,828-28.38%57,291100,71879,82659,363
营业利润1,670,492-28.22%2,563,4242,768,0033,203,1599,247,286
利润总额1,640,180-28.29%2,513,5942,618,8733,181,3539,156,453
减:所得税费用169,604-36.64%286,760139,687339,4121,220,273
净利润1,470,576-27.18%2,226,8342,479,1862,841,9407,936,179
减:非控股权益9,06383.45%6,879721(2,032)(516)
股东净利润1,461,513-27.45%2,219,9552,478,4642,843,9727,936,695

市场价值指针
每股收益 (元) *0.290-29.27%0.4500.5000.5801.710
每股派息 (元) *0.050--0.1500.1500.1500.300
每股净资产 (元) *5.4312.86%5.3315.0224.6644.102
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见--
回页顶
备注: *未调整数据
#只提供简体内容